ELLIS ANDREA sold 43.2% of their position (17.17K shares) of BRIDGEBIO PHARMA, INC. on the open market
Open‑market sale worth $1.44M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/13/2026ACC: 0001470831-26-000709
-17.17K
Net shares
Net seller
$1.44M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
17.17K acquired · 34.33K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+17.17K
Price / share
$16.75
Trade value
$287.55K
% of position
76.0%
7/9/2026
22.58K→39.75K
Common Stock
Direct
Shares
−17.17K
Price / share
$84.00
Trade value
$1.44M
% of position
43.2%
7/9/2026
39.75K→22.58K
Total
Net shares
+0.00
Net value
-$1.15M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/9/2026 | M · Option Exercise | +17.17K | $16.75 | $287.55K | 76.0% | 22.58K | 39.75K |
| Common Stock Direct | 7/9/2026 | S · Sale | −17.17K | $84.00 | $1.44M | 43.2% | 39.75K | 22.58K |
| Total | +0.00 | -$1.15M | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
17.17K shares
Shares
−17.17K
Strike price
16.75
Held after
17.17K
Exercisable
—
7/9/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock17.17K shares | 7/9/2026 | M · Option Exercise | −17.17K | 16.75 | — | 17.17K |